Comparison of Management and Outcomes of Acute Heart Failure Hospitalization in Medicaid Beneficiaries Versus Privately Insured Individuals

      Medicaid expansion in terms of its eligibility and federal funding has led to improved healthcare access in previously uninsured individuals. However, proposed lower Medicaid rates have unintentionally led to lower utilization of substantial life-saving therapies and poor outcomes compared with private insurance. We examined heart failure (HF) management, in-hospital mortality, and resource utilization in Medicaid and privately insured individuals hospitalized with HF. The authors screened the National Inpatient Sample from January 2012 to September 2015 for HF hospitalizations with Medicaid or private insurance as the primary payer. The authors identified a total of 226,265 and 292,070 patients with HF hospitalizations with Medicaid and private insurance, respectively. In propensity-matched cohort of 155,790 hospitalizations in each group, Medicaid beneficiaries with HF hospitalization had lower rates of intra-aortic balloon pump/left ventricular assist device/extracorporeal membrane oxygenation utilization (0.6 vs 0.9%; odds ratio [OR] 0.64; 95% confidence interval [CI] 0.59 to 0.69), heart transplantation (0.15 vs 0.44%; OR 0.35; 95% CI 0.30 to 0.40), implantable cardioverter-defibrillator/cardiac resynchronization therapy/permanent pacemaker (3.3 vs 3.9%; OR 0.84; 95% CI 0.81 to 0.87), and had higher rates of in-hospital mortality (1.9 vs 1.7%; OR 1.12; 95% CI 1.07 to 1.19) compared with privately insured individuals (p <0.001 for both). In conclusion, Medicaid recipients with HF hospitalizations had a lower rate of device utilization, heart transplantation, and a higher rate of in-hospital mortality compared with the privately insured sector. Further studies are needed to explore and understand the variation in the outcomes of HF hospitalizations stratified by insurance status.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • LaPar DJ
        • Stukenborg GJ
        • Guyer RA
        • Stone ML
        • Bhamidipati CM
        • Lau CL
        • Kron IL
        • Ailawadi G
        Primary payer status is associated with mortality and resource utilization for coronary artery bypass grafting.
        Circulation. 2012; 126: S132-S139
        • Doshi R
        • Al-Khafaji JF
        • Dave M
        • Taha M
        • Patel K
        • Goyal H
        • Gullapalli N
        Comparison of baseline characteristics and in-hospital outcomes in medicaid versus private insurance hospitalizations for atrial fibrillation.
        Am J Cardiol. 2019; 123: 776-781
        • Patel N
        • Gupta A
        • Doshi R
        • Kalra R
        • Bajaj NS
        • Arora G
        • Arora P
        In-hospital management and outcomes after ST-segment-elevation myocardial infarction in medicaid beneficiaries compared with privately insured individuals.
        Circ Cardiovasc Qual Outcomes. 2019; 12e004971
        • Selden TM
        • Karaca Z
        • Keenan P
        • White C
        • Kronick R
        The growing difference between public and private payment rates for inpatient hospital care.
        Health Aff (Millwood). 2015; 34: 2147-2150
        • Hannan EL
        • Zhong Y
        • Walford G
        • Jacobs AK
        • Venditti FJ
        • Stamato NJ
        • Holmes Jr., DR
        • Sharma S
        • Gesten F
        • King 3rd, SB
        Underutilization of percutaneous coronary intervention for ST-elevation myocardial infarction in medicaid patients relative to private insurance patients.
        J Interv Cardiol. 2013; 26: 470-481
        • Benjamin EJ
        • Muntner P
        • Alonso A
        • Bittencourt MS
        • Callaway CW
        • Carson AP
        • Chamberlain AM
        • Chang AR
        • Cheng S
        • Das SR
        • Delling FN
        • Djousse L
        • Elkind MSV
        • Ferguson JF
        • Fornage M
        • Jordan LC
        • Khan SS
        • Kissela BM
        • Knutson KL
        • Kwan TW
        • Lackland DT
        • Lewis TT
        • Lichtman JH
        • Longenecker CT
        • Loop MS
        • Lutsey PL
        • Martin SS
        • Matsushita K
        • Moran AE
        • Mussolino ME
        • O'Flaherty M
        • Pandey A
        • Perak AM
        • Rosamond WD
        • Roth GA
        • Sampson UKA
        • Satou GM
        • Schroeder EB
        • Shah SH
        • Spartano NL
        • Stokes A
        • Tirschwell DL
        • Tsao CW
        • Turakhia MP
        • VanWagner LB
        • Wilkins JT
        • Wong SS
        • Virani SS
        • American Heart Association Council on E, Prevention Statistics C and Stroke Statistics S
        Heart disease and stroke statistics-2019 update: a report from the American Heart Association.
        Circulation. 2019; 139: e56-e528
        • van der Meer P
        • Gaggin HK
        • Dec GW
        ACC/AHA versus ESC guidelines on heart failure: JACC guideline comparison.
        J Am Coll Cardiol. 2019; 73: 2756-2768
        • Kalra R
        • Patel N
        • Doshi R
        • Arora G
        • Arora P
        Evaluation of the incidence of new-onset atrial fibrillation after aortic valve replacement.
        JAMA Intern Med. 2019; 179: 1122-1130
        • Ehsan A
        • Zeymo A
        • McDermott J
        • Shara NM
        • Sellke FW
        • Yousefzai R
        • Al-Refaie WB
        Utilization of left ventricular assist devices in vulnerable adults across medicaid expansion.
        J Surg Res. 2019; 243: 503-508
        • Emani S
        • Tumin D
        • Foraker RE
        • Hayes Jr., D
        • Smith SA
        Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
        Clin Transplant. 2017; 31: e12875
        • Hutcheson SS
        • Phillips V
        • Patzer R
        • Smith A
        • Vega JD
        • Morris AA
        Impact of insurance type on eligibility for advanced heart failure therapies and survival.
        Clin Transplant. 2018; 32: e13328
        • Foraker RE
        • Rose KM
        • Suchindran CM
        • Chang PP
        • McNeill AM
        • Rosamond WD
        Socioeconomic status, medicaid coverage, clinical comorbidity, and rehospitalization or death after an incident heart failure hospitalization: atherosclerosis risk in communities cohort (1987 to 2004).
        Circ Heart Fail. 2011; 4: 308-316
        • Kapoor JR
        • Kapoor R
        • Hellkamp AS
        • Hernandez AF
        • Heidenreich PA
        • Fonarow GC
        Payment source, quality of care, and outcomes in patients hospitalized with heart failure.
        J Am Coll Cardiol. 2011; 58: 1465-1471